• Return to Headlines

Earnings Preview: Keryx Biopharmaceuticals's Quarterly Results will be Reported in 12 days (KERX)

Written on Sun, 07/25/2010 - 3:57pm
By Chip Brian

Analysts, on average, expect Keryx Biopharmaceuticals (NASDAQ:KERX) to report a loss of $0.09 on sales of $10 thousand on August 05, 2010.
For the full year, analysts expect the company to post a loss of $0.31. In the year-ago period, the company reported EPS of $0.29 on sales of $18 million.
In the previous quarter, the company reported a loss of $0.07, topping consensus estimates for a loss of $0.08.
SmarTrend is bearish on shares of Keryx Biopharmaceuticals and our subscribers were alerted to Sell on May 20, 2010 at $4.55. The stock has fallen 17.9% since the alert was issued.

Keywords: keryx biopharmaceuticals earnings preview

Ticker(s): KERX

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.